Literature DB >> 32329185

Stromal deactivation by CSF1: a new feature of the aggressive pancreatic cancer microenvironment.

Renzo E Vera1, Martin E Fernandez-Zapico1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with one of the poorest prognosis among all malignancies. The initiation and evolution of this kind of tumor depends on a complex interaction between cancer cells and the tumor microenvironment (TME). In an elegant study, Steins et al [1] used a combination of relevant disease models to show that mesenchymal subtype of PDAC shows a distinct deactivation of stellate cells in a CSF1-dependent fashion. This study shedding light on a new role for the stroma driving an aggressive PDAC subtypes shifts the current paradigm for the requirement of an activated TME to regulate PDAC growth and maintenance.
© 2020 The Authors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32329185      PMCID: PMC7202212          DOI: 10.15252/embr.202050468

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  7 in total

1.  Stromal deactivation by CSF1: a new feature of the aggressive pancreatic cancer microenvironment.

Authors:  Renzo E Vera; Martin E Fernandez-Zapico
Journal:  EMBO Rep       Date:  2020-04-23       Impact factor: 8.807

Review 2.  The biology and function of fibroblasts in cancer.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2016-08-23       Impact factor: 60.716

3.  Pancreatic stellate cells: a starring role in normal and diseased pancreas.

Authors:  Minoti V Apte; Romano C Pirola; Jeremy S Wilson
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

Review 4.  Biology of pancreatic stellate cells-more than just pancreatic cancer.

Authors:  Pawel E Ferdek; Monika A Jakubowska
Journal:  Pflugers Arch       Date:  2017-04-05       Impact factor: 3.657

Review 5.  Role of the tumor microenvironment in pancreatic cancer.

Authors:  Takashi Murakami; Yukihiko Hiroshima; Ryusei Matsuyama; Yuki Homma; Robert M Hoffman; Itaru Endo
Journal:  Ann Gastroenterol Surg       Date:  2019-01-04

Review 6.  Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Andrew McGuigan; Paul Kelly; Richard C Turkington; Claire Jones; Helen G Coleman; R Stephen McCain
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

7.  High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1.

Authors:  Hanneke Wm van Laarhoven; Maarten F Bijlsma; Anne Steins; Madelaine G van Mackelenbergh; Amber P van der Zalm; Remy Klaassen; Bryan Serrels; Sandrine G Goris; Hemant M Kocher; Cynthia Waasdorp; Joan H de Jong; Cansu Tekin; Marc G Besselink; Olivier R Busch; Marc J van de Vijver; Joanne Verheij; Frederike Dijk; Geertjan van Tienhoven; Johanna W Wilmink; Jan Paul Medema
Journal:  EMBO Rep       Date:  2020-03-16       Impact factor: 8.807

  7 in total
  2 in total

1.  Stromal deactivation by CSF1: a new feature of the aggressive pancreatic cancer microenvironment.

Authors:  Renzo E Vera; Martin E Fernandez-Zapico
Journal:  EMBO Rep       Date:  2020-04-23       Impact factor: 8.807

Review 2.  Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' Tumors.

Authors:  Andrea Pelosi; Piera Filomena Fiore; Sabina Di Matteo; Irene Veneziani; Ignazio Caruana; Stefan Ebert; Enrico Munari; Lorenzo Moretta; Enrico Maggi; Bruno Azzarone
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.